adult patients with advanced metastatic solid tumors or NHL

GSK3326595, a PRMT5 inhibitor, displayed modest efficacy and safety signals that were consistent with those that were previously reported with the agent among patients with… Read More »PRMT5 Inhibitor Exhibits Efficacy and Tolerability in NHL, Advanced Solid Tumors